BENGALURU/HYDERABAD (Reuters) – India’s Sun Pharmaceutical Industries reported third-quarter profit above estimates on Wednesday, driven by strong sales in key markets such as the United States.
The company reported a consolidated profit after tax of 24.24 billion rupees ($292 million) for the quarter ended Dec. 31, beating analysts’ estimate of 24.17 billion rupees as per LSEG data.
($1 = 83.0010 Indian rupees)
(Reporting by Kashish Tandon in Bengaluru and Rishika Sadam in Hyderabad; Editing by Mrigank Dhaniwala and Varun H K)
Comments